GO:0008192 RNA guanylyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008192 RNA guanylyltransferase activity catalyzes the posttranscriptional addition of a guanyl residue to the 5' end of an RNA molecule, forming the G cap structure.
• The enzyme uses GTP as a substrate and releases pyrophosphate, forming a covalent enzyme-GMP intermediate before transferring GMP to the 5' diphosphate end of RNA.
• RNA guanylyltransferase is conserved across eukaryotes, viruses, and some prokaryotes; viral enzymes such as vaccinia capping enzyme and Faustovirus capping enzyme are well-characterized models.
• In humans, the RNA guanylyltransferase domain is part of the RNGTT (human capping enzyme) and is essential for mRNA stability, translation, and immune recognition.
• Dysregulation of capping enzymes is linked to cancer, viral pathogenesis, and developmental disorders, making them attractive drug targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of RNA guanylyltransferase function in health and disease.
Description
RNA guanylyltransferase activity (GO:0008192) is a molecular function that catalyzes the addition of a guanyl residue to the 5' end of an RNA molecule, a critical step in the formation of the 5' cap structure. This activity is essential for the maturation, stability, and translation of eukaryotic mRNAs and is also encoded by many viruses to modify host RNA. The reaction proceeds through a covalent enzyme-GMP intermediate and requires GTP as a substrate, releasing pyrophosphate. Researchers study this activity to understand gene expression regulation, viral replication, and to develop antiviral and anticancer therapeutics.
RNA guanylyltransferase activity At A Glance
| GO ID | GO:0008192 |
|---|---|
| GO term | RNA guanylyltransferase activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Catalysis of the posttranscriptional addition of a guanyl residue to the 5' end of an RNA molecule |
| Substrate | GTP |
| Product | 5' guanylylated RNA (G cap) and pyrophosphate |
| Cofactor | Divalent metal ions (e.g., Mg2+ or Mn2+) |
| Localization | Nucleus (eukaryotes), cytoplasm (viruses) |
| EC number | 2.7.7.50 |
What Is GO:0008192?
RNA guanylyltransferase activity (GO:0008192) is defined as the catalysis of the posttranscriptional addition of a guanyl residue to the 5' end of an RNA molecule. This enzymatic step typically follows RNA 5'-triphosphatase activity, which converts the 5' triphosphate to a diphosphate, allowing guanylyltransferase to transfer GMP from GTP to the RNA, forming a 5' G cap. The enzyme forms a covalent enzyme-GMP intermediate and releases pyrophosphate.
Why Is RNA guanylyltransferase activity Important in Cell Biology?
RNA guanylyltransferase activity is essential for the 5' cap formation of eukaryotic mRNAs, which protects transcripts from degradation, facilitates nuclear export, and promotes translation initiation. In viruses, guanylyltransferases are critical for capping viral RNAs to evade host immune responses and ensure efficient viral protein synthesis. Dysregulation of capping enzymes is implicated in cancer, viral infections, and developmental disorders, making them promising therapeutic targets.
• Essential for mRNA stability and translation initiation in eukaryotes.
• Required for viral RNA capping and immune evasion in viruses such as vaccinia, baculovirus, and Faustovirus.
• Involved in the regulation of gene expression at the posttranscriptional level.
• Mutations in capping enzymes can lead to developmental defects and disease.
• Target for antiviral drug development, as many viruses encode their own guanylyltransferases.
• Potential target in cancer therapy, as cancer cells rely on efficient mRNA capping for proliferation.
• Used as a model system to study enzyme mechanism and RNA processing.
• Facilitates the study of RNA modifications and their impact on immunity.
• Enables biotechnological applications such as in vitro RNA synthesis and capping.
• Provides insights into evolutionary conservation of RNA processing machinery.
What Happens During RNA guanylyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme grabs GTP and the RNA end.
RNA guanylyltransferase binds GTP and the 5' diphosphate end of RNA. The enzyme first interacts with GTP, positioning it for catalysis. In eukaryotic systems, the RNA 5'-triphosphatase domain often acts first to generate the diphosphate end, which is the substrate for guanylyltransferase.
Covalent enzyme-GMP intermediate formation
In simple terms: The enzyme temporarily holds onto GMP.
The enzyme catalyzes the release of pyrophosphate from GTP and forms a covalent bond between a conserved lysine residue and GMP. This enzyme-GMP intermediate is a hallmark of the reaction mechanism and has been demonstrated for vaccinia virus capping enzyme and human capping enzyme.
GMP transfer to RNA
In simple terms: The GMP is moved onto the RNA.
The GMP moiety is transferred from the enzyme to the 5' diphosphate end of the RNA, forming a 5' guanylylated RNA (G cap) and releasing the enzyme. This step completes the guanylyltransferase reaction and is essential for subsequent methylation steps in cap formation.
Coupling with RNA 5'-triphosphatase and methyltransferase
In simple terms: Other enzymes help finish the cap.
In many systems, RNA guanylyltransferase is physically associated with RNA 5'-triphosphatase and RNA (guanine-7-)methyltransferase, forming a multifunctional capping enzyme complex. This coupling ensures efficient cap formation and processing.
Key Genes Involved in GO:0008192 RNA guanylyltransferase activity
The following genes and proteins are key players in RNA guanylyltransferase activity across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNGTT (human) | RNA guanylyltransferase and 5'-phosphatase | Central to human mRNA capping; studied in cancer and gene expression |
| CE (vaccinia virus) | Viral capping enzyme with guanylyltransferase and methyltransferase | Model for viral capping and antiviral targets |
| LEF-4 (baculovirus) | RNA polymerase subunit with guanylyltransferase activity | Essential for baculovirus RNA capping |
| VP4 (bluetongue virus) | Guanylyltransferase and RNA 5'-triphosphatase | Viral capping enzyme; potential antiviral target |
| Faustovirus capping enzyme | mRNA capping enzyme with guanylyltransferase | Biochemical model for viral capping |
| Tobacco mosaic virus replicase | Viral-coded guanylyltransferase-like activity | Plant virus capping mechanism |
| Rhabdovirus L protein | Guanylyltransferase activity for viral mRNA capping | Studied for viral transcription and capping |
| Rat liver RNA guanylyltransferase | Nuclear capping enzyme | Early biochemical characterization |
| Human RNGTT | mRNA capping enzyme | Structural and functional studies |
| Vaccinia D1R | Large subunit of capping enzyme | Guanylyltransferase and methyltransferase |
| Vaccinia D12L | Small subunit of capping enzyme | Stimulates guanylyltransferase activity |
| Bluetongue virus VP4 | Capping enzyme | Guanylyltransferase and triphosphatase |
| Baculovirus LEF-4 | RNA polymerase subunit | Guanylyltransferase activity |
| Faustovirus mRNA capping enzyme | Capping enzyme | Biochemical characterization |
| Rhabdovirus guanylyltransferase | Viral capping enzyme | In vitro capping assays |
| Tobacco mosaic virus capping enzyme | Viral guanylyltransferase-like | Plant virus capping |
| Human capping enzyme (RNGTT) | mRNA capping | Co-transcriptional capping |
How Is RNA guanylyltransferase activity Regulated?
RNA guanylyltransferase activity is regulated at multiple levels. In eukaryotes, the enzyme is part of a multifunctional complex that is recruited to the RNA polymerase II C-terminal domain (CTD) during transcription, ensuring co-transcriptional capping. Phosphorylation of the CTD regulates the recruitment and activity of the capping enzyme. In viruses, guanylyltransferase activity can be modulated by viral proteins and host factors to optimize viral RNA capping. Additionally, the enzyme's activity can be influenced by divalent metal ions and posttranslational modifications.
RNA guanylyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNGTT | Cancer, developmental disorders | Knockout and point-mutation cell lines |
| Vaccinia virus CE | Viral infection | Viral infection models with knockout of host capping enzyme |
| Faustovirus capping enzyme | Viral pathogenesis | In vitro capping assays and viral replication models |
| Bluetongue virus VP4 | Viral infection | Knockout of VP4 in viral genome |
| Baculovirus LEF-4 | Viral infection | Knockout and overexpression in insect cells |
Cancer
Dysregulation of mRNA capping enzymes, including RNA guanylyltransferase, has been implicated in cancer. Overexpression of capping enzymes can enhance the translation of oncogenic mRNAs, promoting tumor growth. Targeting capping enzymes is being explored as a therapeutic strategy in cancers dependent on efficient mRNA capping.
Viral infections
Many viruses encode their own RNA guanylyltransferase to cap viral RNAs, which helps them evade host immune detection and efficiently translate viral proteins. Inhibiting viral guanylyltransferases is a promising antiviral approach, as demonstrated for vaccinia virus and Faustovirus.
Developmental disorders
Mutations in genes encoding capping enzymes can lead to developmental defects due to impaired mRNA processing. While specific disorders linked to RNA guanylyltransferase are still being defined, the essential role of capping in gene expression suggests that disruptions could cause severe phenotypes.
From RNA guanylyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of RNGTT knockout on cell viability? | CRISPR knockout in human cell lines |
| How does a point mutation in the catalytic lysine affect guanylyltransferase activity? | Point-mutation knock-in via CRISPR |
| What is the subcellular localization of RNGTT? | Tagged knock-in with fluorescent protein |
| Does overexpression of RNGTT enhance mRNA capping? | Overexpression cell lines |
| Can viral guanylyltransferase be inhibited by small molecules? | In vitro enzymatic assays with recombinant enzyme |
| What are the interactors of RNGTT? | Affinity purification followed by mass spectrometry |
How to Study the RNA guanylyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GTP-pyrophosphate exchange assay | Guanylyltransferase activity | Enzyme kinetics and inhibitor screening |
| Covalent enzyme-GMP intermediate assay | Formation of enzyme-GMP complex | Mechanistic studies |
| In vitro capping assay | Transfer of GMP to RNA | Viral capping enzyme characterization |
| RNA-seq | Global mRNA levels and capping status | Knockout/overexpression studies |
| CRISPR knockout screens | Gene essentiality and drug sensitivity | Identifying synthetic lethal interactions |
| Structural biology (X-ray/cryo-EM) | 3D structure of enzyme-substrate complex | Mechanistic insights and drug design |
| Mass spectrometry | Protein interactions and modifications | Identifying capping enzyme complex components |
| Fluorescence microscopy | Subcellular localization | Tagged knock-in cell lines |
In vitro guanylyltransferase assays
In vitro assays using recombinant enzyme and radiolabeled GTP measure the formation of enzyme-GMP intermediate and GMP transfer to RNA. These assays are used to determine kinetic parameters and screen inhibitors.
RNA sequencing and capping analysis
RNA-seq and specialized capping assays (e.g., Cap-seq) can assess the impact of guanylyltransferase mutations on global mRNA capping and gene expression.
Structural biology
X-ray crystallography and cryo-EM have provided insights into the structure of human and viral capping enzymes, revealing the catalytic mechanism and substrate binding.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to guanylyltransferase inhibitors or regulate capping efficiency.
How CRISPR Can Be Used to Study GO:0008192 RNA guanylyltransferase activity
Knockout
CRISPR knockout of RNGTT or viral guanylyltransferase genes can abolish capping activity, leading to mRNA instability and cell death, thus validating the essential function. Knockout models are used to study the consequences of loss of guanylyltransferase activity in cancer and viral infection.
Point Mutation
Point mutations in the catalytic lysine or other key residues can be introduced via CRISPR to dissect the enzymatic mechanism and separate guanylyltransferase activity from other domains. Such models help identify residues critical for catalysis and substrate binding.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of RNGTT allows for localization, interaction, and real-time activity studies. Knock-in of disease-associated mutations can model human disorders.
Overexpression
Overexpression of wild-type or mutant guanylyltransferase can enhance or disrupt mRNA capping, affecting translation and cell growth. Overexpression models are useful for studying gain-of-function effects and drug resistance.
How EDITGENE Supports RNA guanylyltransferase activity Research
Researchers studying RNA guanylyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in capping, RNA stability, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for RNA guanylyltransferase activity research.
Frequently Asked Questions About RNA guanylyltransferase activity
What is RNA guanylyltransferase activity?
RNA guanylyltransferase activity (GO:0008192) is the catalysis of the posttranscriptional addition of a guanyl residue to the 5' end of an RNA molecule, forming the 5' cap structure.
What genes are involved in RNA guanylyltransferase activity?
Key genes include RNGTT in humans, vaccinia virus capping enzyme, baculovirus LEF-4, bluetongue virus VP4, and Faustovirus capping enzyme.
What is the mechanism of RNA guanylyltransferase?
The enzyme binds GTP, forms a covalent enzyme-GMP intermediate, and transfers GMP to the 5' diphosphate end of RNA, releasing pyrophosphate.
Why is RNA guanylyltransferase important?
It is essential for mRNA stability, translation, and immune evasion by viruses, and is a target for antiviral and anticancer therapies.
How is RNA guanylyltransferase activity measured?
In vitro assays using radiolabeled GTP, GTP-pyrophosphate exchange, and capping assays are commonly used.
What diseases are associated with RNA guanylyltransferase?
Cancer and viral infections are linked to dysregulation of capping enzymes.
Can CRISPR be used to study RNA guanylyltransferase?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies.
What is the role of RNA guanylyltransferase in viruses?
Viruses encode their own guanylyltransferases to cap viral RNAs, aiding immune evasion and translation.
What is the difference between RNA guanylyltransferase and RNA 5'-triphosphatase?
RNA 5'-triphosphatase removes the gamma phosphate from the 5' triphosphate, while guanylyltransferase adds GMP to the resulting diphosphate.
How does RNA guanylyltransferase contribute to mRNA capping?
It adds the guanine cap structure to the 5' end of mRNA, which is the first step in cap formation.
Conclusion
RNA guanylyltransferase activity (GO:0008192) is a fundamental enzymatic function in RNA processing, essential for mRNA stability, translation, and viral replication. Its conservation across species and critical role in gene expression make it a key research focus. Understanding its mechanism and regulation offers insights into human disease and provides opportunities for therapeutic intervention. EDITGENE's CRISPR services empower researchers to create precise models for studying this activity in health and disease.
References
- 1. Yagi Y et al.. 1983. Association of an RNA 5'-triphosphatase activity with RNA guanylyltransferase partially purified from rat liver nuclei.. EMBO J 2(4):611-5 PMID: 6138253
- 2. Guarino LA et al.. 1998. Guanylyltransferase activity of the LEF-4 subunit of baculovirus RNA polymerase.. J Virol 72(12):10003-10 PMID: 9811738
- 3. Dunigan DD et al.. 1990. Capping of tobacco mosaic virus RNA. Analysis of viral-coded guanylyltransferase-like activity.. J Biol Chem 265(14):7779-86 PMID: 2159456
- 4. Shuman S et al.. 1980. Purification and characterization of a GTP-pyrophosphate exchange activity from vaccinia virions. Association of the GTP-pyrophosphate exchange activity with vaccinia mRNA guanylyltransferase . RNA (guanine-7-)methyltransferase complex (capping enzyme).. J Biol Chem 255(23):11588-98 PMID: 6254974
- 5. Garg G et al.. 2023. Structural insights into human co-transcriptional capping.. Mol Cell 83(14):2464-2477.e5 PMID: 37369200
- 6. Chan SH et al.. 2023. Biochemical characterization of mRNA capping enzyme from Faustovirus.. RNA 29(11):1803-1817 PMID: 37625853
- 7. Martinez-Costas J et al.. 1998. Guanylyltransferase and RNA 5'-triphosphatase activities of the purified expressed VP4 protein of bluetongue virus.. J Mol Biol 280(5):859-66 PMID: 9671555
- 8. Ogino T. 2013. In vitro capping and transcription of rhabdoviruses.. Methods 59(2):188-98 PMID: 22687619
